They bypass digestion to provide 100% absorption, replenishing natural antioxidant levels that protect against toxins, stress, and free-radical damage
Coding Guidelines and Notes Code First: For both L89 and L97, code any underlying conditions first, such as peripheral vascular disease, diabetes, or associated gangrene
This includes reviewing any existing conditions like gastroparesis to ensure the safest and most effective path forward
Differentiating between direct anti-inflammatory properties of tirzepatide and the indirect benefits of weight reduction presents a significant clinical and research challenge
Stool Form Scale as a Useful Guide to Intestinal Transit Time
The SURMOUNT-1 trial of tirzepatide reported 4.3-7.1% across dose groups